Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$620,000 |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$344M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$30,000 |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Rowe Michael M | Aug 28, 2024 | Buy | 27,071 | $0.52 | $14,000 |
| Rowe Michael M | Aug 26, 2024 | Buy | 50,000 | $0.57 | $29,000 |
| Grant Stuart M. | Jul 2, 2024 | Buy | 1,515,151 | $0.66 | $1,000,000 |
| Grant Stuart M. | Mar 28, 2024 | Buy | 100,000 | $0.98 | $98,000 |
| Grant Stuart M. | Mar 19, 2024 | Buy | 50,000 | $1.23 | $62,000 |
| Grant Stuart M. | Mar 8, 2024 | Buy | 10,717 | $1.578 | $17,000 |
| Rowe Michael M | Dec 4, 2023 | Buy | 4,890 | $1.36 | $6,700 |
| Strahlman Ellen R | Sep 29, 2023 | Buy | 4,820 | $1.68 | $8,100 |
| Rowe Michael M | Sep 19, 2023 | Buy | 1,400 | $1.66 | $2,300 |
| Rowe Michael M | Sep 15, 2023 | Buy | 1,137 | $1.75 | $2,000 |
| Grant Stuart M. | Aug 17, 2023 | Buy | 30,000 | $1.87 | $56,000 |
| Grant Stuart M. | Aug 16, 2023 | Buy | 45,000 | $1.907 | $86,000 |
| GANDOLFO JOHN P | May 31, 2023 | Buy | 2,000 | $2.79 | $5,600 |
| Kern Bren | May 26, 2023 | Buy | 2,500 | $2.73 | $6,800 |
| MATHER CHARLES E IV | May 26, 2023 | Buy | 3,000 | $2.4899 | $7,500 |
| Grant Stuart M. | May 25, 2023 | Buy | 88,247 | $2.65 | $230,000 |
| Strahlman Ellen R | May 23, 2023 | Buy | 10,000 | $3.0976 | $31,000 |
| MATHER CHARLES E IV | May 15, 2023 | Buy | 4,000 | $3.39 | $14,000 |
| Ianchulev Tsontcho | May 1, 2023 | Sell | 90,000 | $5.5 | $500,000 |
| Ianchulev Tsontcho | Apr 27, 2023 | Sell | 60,000 | $5 | $300,000 |
| Ianchulev Tsontcho | Apr 14, 2023 | Sell | 40,000 | $4.5 | $180,000 |
| Ianchulev Tsontcho | Apr 11, 2023 | Sell | 40,000 | $4 | $160,000 |
| Ianchulev Tsontcho | Mar 31, 2023 | Sell | 40,000 | $3.5 | $140,000 |
What's the latest insider transaction for Eyenovia?
The most recent insider transaction for Eyenovia was conducted by Rowe Michael M, who sold 27,071 shares on August 28, 2024 at a price of $0.52 per share.
Which insider bought the most EYEN stock over the last two years?
Grant Stuart M. has bought the most EYEN stock in the last 2 years, with a total value of $1.6M.
Which insider has sold the most EYEN stock over the last two years?
Ianchulev Tsontcho has sold the most EYEN stock in the last 2 years, with a total value of $1.3M.
What is the total value of insider transactions for Eyenovia (EYEN) in the last 2 years?
According to our estimates, the total value of insider transactions for Eyenovia in the last 2 years is positive, amounting to $400,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Eyenovia's market confidence?
Over the last 2 years, insider transactions for Eyenovia have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
